XOMA Corp (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has initiated its Phase 2 proof-of-concept study for …
XOMA Corp (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, announced recent operational achievements and financial results for the first quarter …
XOMA Corp (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, announced today it has initiated its proof-of-concept study to evaluate the …
XOMA Corp (NASDAQ:XOMA), a leader in the discovery and development of therapeutic antibodies, announced the presentation of data from XOMA 129, the lead compound …
Healthcare analysts came out today with research notes on a handful of biotechnology and medical stocks. Among the equities in focus are cancer …
Canadian Solar Inc. (NASDAQ:CSIQ) is falling 6% in pre-market trading after reporting fourth earnings results.
The New Year brings another turbulent season for biotech investors as top-line data continues to be released and the FDA’s approval process marches …
The biotechnology sector is very fast-paced as every event, such as new data, FDA decisions, and trial initiations can double or deplete a …
Liana Moussatos of Wedbush rates stocks in the biotechnology sector and is one of the top 50 analysts rated on TipRanks. Today, Moussatos reiterated ratings for …
Yahoo! Inc.
